Clinical trial
Comparison of Safety and Efficacy of Coronary Drug-coated Balloon (DCB) Combined With Spot Stenting of Drug-eluting Stent (DES) Versus Second-generation DES for Treating Diffuse Coronary Artery Lesions: a Prospective, Randomized, Controlled Clinical Trial
NCT03589157 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Safety and Efficacy of Coronary Drug-coated Balloon (DCB) Combined With Spot Stenting of Drug-eluting Stent (DES) Versus Second-generation DES for Treating Diffuse Coronary Artery Lesions: a Prospective, Randomized, Controlled Clinical Trial
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 15, 2018
- Completion date
- June 30, 2022
- Enrollment
- 140 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diffuse coronary artery lesions